Pulmonary arterial hypertension (PAH) is a rare and severe disease that continues to progress over time. It is caused by the narrowing of the pulmonary arteries, which connect the right side of the heart to the lungs. PAH may occur with no identifiable cause or may be associated with one or more underlying conditions. As PAH develops, blood flow through the pulmonary arteries is restricted and the right side of the heart becomes enlarged due to the increased strain of pumping blood through the lungs.
While the exact cause of PAH is uncertain, a clearer picture of the underlying pathological mechanisms is emerging.
Clinical guidelines set out the diagnostic pathway so patients can be referred and treated as quickly as possible.
Modern treatments can significantly improve patients’ symptoms and slow the rate of clinical deterioration.
Diagnostic tools, expert opinion videos and educational aids to help you identify, assess and manage your PAH patients.
Question or remark related PAH, the studies or our products? Click below to get in touch with a product specialist or medical science liaison.
For over 20 years, we have been working with HCP’s in order to help transform the management of PAH with our treatments.